EA200700613A1 - Метаболически активные микроорганизмы и способы их получения - Google Patents

Метаболически активные микроорганизмы и способы их получения

Info

Publication number
EA200700613A1
EA200700613A1 EA200700613A EA200700613A EA200700613A1 EA 200700613 A1 EA200700613 A1 EA 200700613A1 EA 200700613 A EA200700613 A EA 200700613A EA 200700613 A EA200700613 A EA 200700613A EA 200700613 A1 EA200700613 A1 EA 200700613A1
Authority
EA
Eurasian Patent Office
Prior art keywords
metabolically active
methods
receiving
active microorganisms
microorganisms
Prior art date
Application number
EA200700613A
Other languages
English (en)
Other versions
EA012968B1 (ru
Inventor
Тимоти Терлби
Original Assignee
Малтиджерм Ю-Кей Энтерпрайзис Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Малтиджерм Ю-Кей Энтерпрайзис Лтд. filed Critical Малтиджерм Ю-Кей Энтерпрайзис Лтд.
Publication of EA200700613A1 publication Critical patent/EA200700613A1/ru
Publication of EA012968B1 publication Critical patent/EA012968B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к препарату метаболически активных бактерий, композициям, содержащим такой препарат, например пробиотическим добавкам или кормам для животных, и к их применению, например в лечении заболеваний, нарушающих микробный баланс кишечника. Также описан ростовой субстрат для микроорганизмов, содержащий смесь сложных и простых сахаров, и способ изготовления препаратов метаболически активных микроорганизмов с использованием этого ростового субстрата.
EA200700613A 2004-09-27 2005-09-27 Препарат, содержащий пробиотические бактерии, способы его получения, продукты на его основе, их применение и ростовой субстрат EA012968B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0421448A GB2418431A (en) 2004-09-27 2004-09-27 Metabolically active micro organisms and methods for their production
PCT/GB2005/003715 WO2006035218A1 (en) 2004-09-27 2005-09-27 Metabolically active micro organisms and methods for their production

Publications (2)

Publication Number Publication Date
EA200700613A1 true EA200700613A1 (ru) 2007-10-26
EA012968B1 EA012968B1 (ru) 2010-02-26

Family

ID=33397330

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700613A EA012968B1 (ru) 2004-09-27 2005-09-27 Препарат, содержащий пробиотические бактерии, способы его получения, продукты на его основе, их применение и ростовой субстрат

Country Status (15)

Country Link
US (2) US8551473B2 (ru)
EP (2) EP1794283B1 (ru)
JP (1) JP5577020B2 (ru)
CN (2) CN101603021B (ru)
AU (1) AU2005288751B2 (ru)
CA (1) CA2580949C (ru)
EA (1) EA012968B1 (ru)
ES (2) ES2568955T3 (ru)
GB (1) GB2418431A (ru)
HK (1) HK1134686A1 (ru)
NO (1) NO20072210L (ru)
NZ (1) NZ553858A (ru)
PL (2) PL3050960T3 (ru)
WO (1) WO2006035218A1 (ru)
ZA (1) ZA200702398B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418431A (en) 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
ES2719096T3 (es) * 2008-11-21 2019-07-08 Cruz Serrano Jose Antonio Método para obtener una mezcla de probióticos, prebióticos nutrientes con acción simbiótica sinérgica
GB201119774D0 (en) * 2011-11-16 2011-12-28 Multigerm Uk Entpr Ltd IBS treatment
ES2963547T3 (es) * 2011-11-16 2024-03-27 Multigerm Uk Entpr Ltd Tratamiento del IBS con probióticos
GB201219873D0 (en) * 2012-11-05 2012-12-19 Multigerm Uk Entpr Ltd Diverticulitis treatment
DE102012110612A1 (de) * 2012-11-06 2014-05-08 Gelita Ag Kollagenhydrolysat und dessen Verwendung
CN105296541A (zh) * 2014-07-30 2016-02-03 无限极（中国）有限公司 燕麦发酵液及其制备方法与作为化妆品原料的应用
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
GB201501938D0 (en) 2015-02-05 2015-03-25 Multigerm Uk Entpr Ltd Probiotic preparation
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN108315279A (zh) * 2018-04-09 2018-07-24 河南科技大学 一种植物乳杆菌液体制剂的长时间储存方法
AU2019289190A1 (en) * 2018-06-19 2021-01-07 4D Pharma Research Ltd Dosage form comprising a live biotherapeutic product
JPWO2020013239A1 (ja) * 2018-07-10 2021-05-13 学校法人慶應義塾 Ｄ−プシコース応答性増殖能を有する腸内細菌
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
CN109486713B (zh) * 2018-12-06 2021-03-09 福建傲农生物科技集团股份有限公司 一种液态复合乳酸杆菌制剂及其制备方法与应用
GB201915144D0 (en) 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
WO2021113850A2 (en) * 2019-12-06 2021-06-10 Nas Bioventures Llc Onsite installation or manufactured product of eco-friendly bacterial compositions, methods and systems for bioremediation in a short duration in different environments
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
GB202210523D0 (en) 2022-07-18 2022-08-31 Multigerm Uk Entpr Ltd Probiotic compositions and therapeutic uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906212A (en) * 1960-08-04 1962-09-19 Lilly Co Eli The antibiotic valacidin and its salts and methods for producing same
US3623956A (en) * 1970-01-21 1971-11-30 Rapidase Sa Soc Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis
US3846397A (en) * 1970-04-06 1974-11-05 J Ernster Process for utilizing barley malt
US4464402A (en) * 1978-04-24 1984-08-07 F.I.N.D. Research Corporation Process for manufacturing a high protein food material
US4275164A (en) * 1979-11-05 1981-06-23 Eastman Kodak Company Process and nutrient medium for growing microorganism
EP0189657B1 (en) * 1984-12-12 1989-03-01 WHITBREAD & COMPANY PLC A brewing process
JPS63273469A (ja) * 1986-12-13 1988-11-10 Kyowa Hakko Kogyo Co Ltd 乳糖資化性を有する新規微生物
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
JP2835894B2 (ja) * 1991-07-26 1998-12-14 農林水産省食品総合研究所長 ビフィズス菌増殖促進剤
JPH08259450A (ja) * 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
IE960360A1 (en) * 1996-05-23 1997-12-31 Valdosa Limited A brewing process
CZ296732B6 (cs) * 1996-08-05 2006-05-17 Syngenta Mogen B.V. Zpusob výroby alkoholických nápoju
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
FR2777424B1 (fr) * 1998-04-15 2000-06-16 Lesaffre & Cie Levain panaire longue conservation pret a l'emploi
US6420146B1 (en) * 2000-03-30 2002-07-16 Council Of Scientific & Industrial Research Process for the preparation of stable yeast crystals for enhanced production of ethanol
JP4424643B2 (ja) * 2002-02-13 2010-03-03 株式会社バイオバンク 抗真菌剤の製造方法
GB2391554B (en) * 2002-08-06 2005-09-14 Heineken Ireland Ltd A stout manufacturing process
GB2418431A (en) 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production

Also Published As

Publication number Publication date
WO2006035218A1 (en) 2006-04-06
NO20072210L (no) 2007-04-27
AU2005288751B2 (en) 2010-12-23
CN101603021B (zh) 2013-04-24
JP5577020B2 (ja) 2014-08-20
EP3050960A1 (en) 2016-08-03
ES2654246T3 (es) 2018-02-12
AU2005288751A1 (en) 2006-04-06
GB0421448D0 (en) 2004-10-27
CN100537740C (zh) 2009-09-09
HK1134686A1 (en) 2010-05-07
ZA200702398B (en) 2008-10-29
EP1794283B1 (en) 2016-04-13
JP2008514582A (ja) 2008-05-08
CA2580949C (en) 2017-07-25
EP3050960B1 (en) 2017-12-13
CN101027387A (zh) 2007-08-29
US20130011368A1 (en) 2013-01-10
CA2580949A1 (en) 2006-04-06
PL3050960T3 (pl) 2018-05-30
EA012968B1 (ru) 2010-02-26
CN101603021A (zh) 2009-12-16
EP1794283A1 (en) 2007-06-13
ES2568955T3 (es) 2016-05-05
NZ553858A (en) 2009-01-31
GB2418431A (en) 2006-03-29
PL1794283T3 (pl) 2016-10-31
US8551473B2 (en) 2013-10-08
US20110158949A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
EA200700613A1 (ru) Метаболически активные микроорганизмы и способы их получения
Sonnenschein et al. Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis
GEP20196963B (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MY143795A (en) Tetrahydropyridoindole derivatives
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
NZ519980A (en) Pet food composition for treating helicobacter species in pets
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
WO2005094439A3 (en) Method for diluting hypochlorite
TW200744639A (en) Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
HK1083590A1 (en) Composition containing beta-glucan
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
Sayyed et al. Siderophore production by Alcaligenes faecalis and its application for growth promotion in Arachis hypogaea
MX2020010976A (es) Siloxanos biocompatibles para formulacion de microorganismos.
AU8180001A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells
MX2023003089A (es) Formas farmaceuticas solidas de bacterias.
WO2001010901A3 (en) Antimicrobial histone h1 compositions, kits, and methods of use thereof
Anutrakunchai et al. Drug susceptibility and biofilm formation of Burkholderia pseudomallei in nutrient-limited condition.
DE69927930D1 (de) Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
MX2021009443A (es) Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas.
EA200970614A1 (ru) Средства для стимуляции продуцирования iga
ATE414538T1 (de) Behandlung zur reduzierung der zunahme des körpergewichts

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM